Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Han Chuan Zupa granule plus standard treatment for chronic airway diseases
ChiCTR1900025228Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital, Anhui Medical University
- Start
- Sep 2019
- Countries
- 1
01
Overview
Phase 4, open-label trial of Hanchuan Zupa Granule in asthma and chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by The First Affiliated Hospital, Anhui Medical University. Primary endpoints: Pulmonary function, Clinical symptom score and 6 more. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
Hanchuan Zupa Granule
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR1900025228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025228.